Practice
Featured experience
Incora emerges from chapter 11
We advised an ad hoc group of secured noteholders in connection with Incora’s chapter 11 proceedings
Venture Global $1.75 billion IPO
We advised Venture Global on its IPO and NYSE listing
Interactive Brokers claims for domestic production activities deductions
We are representing Interactive Brokers
Advice to multiple companies on potential tax refunds under the Varian ruling
We are representing clients in refund claims
Morgan Stanley $4 billion senior notes offering
We advised Morgan Stanley on its SEC-registered global offering
Morgan Stanley Bank $2 billion senior notes offering
We advised Morgan Stanley Bank on its 3(a)(2) notes offering
Forbion European Acquisition $138 million combination with enGene
We advised Forbion European Acquisition on its de-SPAC transaction
Air Methods files chapter 11; $155 million DIP and $335 million exit financing
We are advising an ad hoc group of first-lien lenders and unsecured noteholders in connection with Air Methods’ chapter 11…
GSK exclusive license agreement for HS-20089 with Hansoh Pharma
We advised GSK on the transaction
IDEAYA Biosciences $143.8 million equity offering
The common stock is listed on the Nasdaq Global Select Market
Vinci Partners $100 million placement and strategic partnership with Ares
We advised Vinci Partners on the private placement
UCT acquisition of HIS Innovations Group
We advised UCT on the acquisition
Semtech $250 million convertible senior notes offering
We advised Semtech on its private placement of 4% convertible senior notes due 2028
J.M. Smucker $3.5 billion notes offering
The investment-grade debt offering comprises four tranches of notes